A significant driver of top-line growth: AIM ImmunoTech Inc (AIM)

With 1.46 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.08 million shares. The 52-week range on AIM shows that it touched its highest point at $0.62 and its lowest point at $0.11 during that stretch. It currently has a 1-year price target of $4.50. Beta for the stock currently stands at 0.75.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AIM was up-trending over the past week, with a rise of 1.30%, but this was down by -15.08% over a month. Three-month performance dropped to -39.05% while six-month performance fell -61.89%. The stock lost -67.45% in the past year, while it has lost -36.87% so far this year. A look at the trailing 12-month EPS for AIM yields -0.47 with Next year EPS estimates of -0.35. For the next quarter, that number is -0.09. This implies an EPS growth rate of 50.00% for this year and -16.67% for next year.

Float and Shares Shorts:

At present, 68.75 million AIM shares are outstanding with a float of 60.63 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AIM since 1 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.03428571 being high and -$0.63429 being low. For AIM, this leads to a yearly average estimate of -$0.3. Based on analyst estimates, the high estimate for the next quarter is -$0.09 and the low estimate is -$0.09. The average estimate for the next quarter is thus -$0.09.